ArticleJournal of mid-life health
Association between Menopausal Symptoms and Demographic Variables among Perimenopausal and Postmenopausal Women: A Community-based Cross-sectional Survey.
Article in Journal of mid-life health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Menopausal symptoms (MS) present painful experiences that have adverse effects on the overall health of women. The purpose of this study is to determine the prevalence of MS and its association with demographic variables among perimenopausal and postmenopausal women in Nsukka communities. Subjects and Methods: It was a community-based cross-sectional survey adopting a multistage sampling technique, conducted from September 2024 to February 2025 in 30 communities. A total of 850 women of perimenopausal and postmenopausal status were investigated using an adapted menopause symptoms assessment questionnaire, demonstrating a 0.86 reliability index. The IBM-SPSS version 22 was used for data computation, whereas all statistical analysis was performed using frequency, percentage, and Chi-square statistics at Results: Out of 850 eligible participants, only 26 (30.1%) declined, whereas 824 (96.9%) complied accordingly; 523 (63.5%) were perimenopausal, whereas 301 (36.5%) were postmenopausal women, respectively. Overall, MS prevalence was 76.1% for perimenopausal; and 82.4% for postmenopausal women. Specifically, the prevalence of somatic (57%) and (55.5%); psychological (68.3%) and (67.7%); and urogenital symptoms (58.2%) and (65.6%) for perimenopausal and postmenopausal women was found. Statistically, MS was significantly associated with education ( Conclusion: The prevalence of MS was higher among postmenopausal women. The perimenopausal women had higher prevalence of somatic and psychological symptoms. MS was significantly associated with variables, suggesting the need for a community-based health program to reducing MS in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.